Advertisement
GKOS vs ISRG
Which Stock Would AI Choose? Glaukos Corporation (GKOS) vs. Intuitive Surgical, Inc. (ISRG) Stock Comparison
Key Takeaways
- Glaukos Corporation (GKOS) has delivered stronger recent revenue growth and raised its full-year 2026 sales guidance following robust second-quarter results.
- Intuitive Surgical, Inc. (ISRG) maintains a dominant position in robotic-assisted surgery but has faced moderating procedure growth and increased competition.
- GKOS stock has shown notable year-to-date gains and trades near the upper end of its 52-week range, while ISRG has experienced a pullback from recent highs.
- Both companies operate in the healthcare equipment sector with exposure to medical device innovation, though GKOS focuses on ophthalmology and ISRG on minimally invasive surgical systems.
- Institutional interest in GKOS has increased, including new positions disclosed in recent filings, amid positive analyst sentiment.
- Relative performance highlights trade-offs between GKOS’s higher-growth momentum profile and ISRG’s larger scale and established profitability.
Introduction
This comparison examines Glaukos Corporation (GKOS) and Intuitive Surgical, Inc. (ISRG), two healthcare equipment companies with distinct focuses within medical technology. GKOS specializes in ophthalmic therapies for glaucoma and corneal conditions, while ISRG leads in robotic-assisted surgical systems. The analysis is relevant for traders and investors seeking to understand relative performance, growth drivers, and market positioning in the current environment. It draws on recent market activity, financial metrics, and sector dynamics to provide a balanced view suitable for those evaluating opportunities in medical devices.
GKOS Overview and Recent Performance
Glaukos Corporation (GKOS) develops therapies and devices for glaucoma, corneal disorders, and related ophthalmic conditions. In recent market activity, the stock has demonstrated resilience and upward momentum, trading near the upper portion of its 52-week range after posting strong year-to-date gains. Second-quarter 2026 results showed record net sales with significant year-over-year increases, prompting the company to raise its full-year guidance. Factors influencing sentiment include strong uptake of key products such as iDose TR and Epioxa, alongside institutional accumulation noted in recent filings. Performance has been supported by execution across commercial and development priorities amid broader healthcare sector rotation.
ISRG Overview and Recent Performance
Intuitive Surgical, Inc. (ISRG) develops and markets robotic-assisted surgical systems, primarily the da Vinci platform, enabling minimally invasive procedures. Recent market activity has reflected a more measured trajectory, with the stock pulling back from prior highs amid signs of moderating U.S. procedure growth and emerging competition. Second-quarter 2026 results exceeded expectations on revenue and earnings, yet investor focus shifted toward the pace of adoption and forward outlook. Sentiment has been shaped by the company’s scale advantages and international expansion, tempered by competitive pressures in the robotic surgery space and broader valuation considerations in the healthcare equipment sector.
Trending AI Robots
Tickeron’s Trending AI Robots page highlights a curated selection of AI trading bots optimized for prevailing market conditions. Tickeron offers hundreds of AI Trading Bots that trade thousands of different tickers, featuring varied trading styles, strategies, timeframes, performances, statistics, and ticker sets. Only the strongest and most suitable bots for current environments earn placement in this section, with available bots displaying a range of historical win rates, return metrics, and risk parameters that can appeal to diverse investor preferences. This resource provides traders with data-driven options tailored to specific market dynamics.
Head-to-Head Comparison
Glaukos Corporation (GKOS) and Intuitive Surgical, Inc. (ISRG) differ markedly in scale, business focus, and financial profile. GKOS operates as a smaller-cap innovator in ophthalmology with rapid revenue expansion driven by new product launches, while ISRG commands a much larger market capitalization and benefits from established leadership in robotic surgery with more consistent profitability. Recent momentum favors GKOS through stronger year-to-date performance and guidance upgrades, whereas ISRG contends with slower procedure growth and competitive headwinds. Risk factors for GKOS include reimbursement uncertainty and ongoing losses, contrasted with ISRG’s exposure to capital equipment cycles and regulatory scrutiny. Sector exposure overlaps in healthcare equipment, yet GKOS offers higher-beta growth characteristics and ISRG provides greater stability tied to procedure volumes. Market sentiment reflects these contrasts, with GKOS attracting attention for its expansion trajectory and ISRG valued for its entrenched position despite near-term pressures.
Tickeron AI Verdict
Based on observable factors including trend consistency, revenue growth rates, and relative positioning in recent market activity, Tickeron’s AI would currently assign a probabilistic preference to Glaukos Corporation (GKOS). The stock’s stronger recent execution and momentum signals provide a more favorable profile under current conditions compared with Intuitive Surgical, Inc. (ISRG)’s moderating growth trajectory. This assessment remains probabilistic and subject to ongoing market developments.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GKOS is a StrongBuy and ISRG is a Buy.
GKOS | ISRG | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 80 | 37 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 95 Overvalued | 76 Overvalued | |
PROFIT vs RISK RATING 1..100 | 40 | 87 | |
SMR RATING 1..100 | 96 | 51 | |
PRICE GROWTH RATING 1..100 | 38 | 53 | |
P/E GROWTH RATING 1..100 | 46 | 66 | |
SEASONALITY SCORE 1..100 | 39 | 85 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ISRG's Valuation (76) in the Medical Specialties industry is in the same range as GKOS (95). This means that ISRG’s stock grew similarly to GKOS’s over the last 12 months.
GKOS's Profit vs Risk Rating (40) in the Medical Specialties industry is somewhat better than the same rating for ISRG (87). This means that GKOS’s stock grew somewhat faster than ISRG’s over the last 12 months.
ISRG's SMR Rating (51) in the Medical Specialties industry is somewhat better than the same rating for GKOS (96). This means that ISRG’s stock grew somewhat faster than GKOS’s over the last 12 months.
GKOS's Price Growth Rating (38) in the Medical Specialties industry is in the same range as ISRG (53). This means that GKOS’s stock grew similarly to ISRG’s over the last 12 months.
GKOS's P/E Growth Rating (46) in the Medical Specialties industry is in the same range as ISRG (66). This means that GKOS’s stock grew similarly to ISRG’s over the last 12 months.
| GKOS | ISRG | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 85% | 2 days ago 29% |
| Stochastic ODDS (%) | 2 days ago 87% | 2 days ago 52% |
| Momentum ODDS (%) | 2 days ago 88% | 2 days ago 68% |
| MACD ODDS (%) | N/A | 2 days ago 61% |
| TrendWeek ODDS (%) | 2 days ago 79% | 2 days ago 64% |
| TrendMonth ODDS (%) | 2 days ago 66% | 2 days ago 64% |
| Advances ODDS (%) | 18 days ago 78% | 5 days ago 67% |
| Declines ODDS (%) | 10 days ago 67% | 2 days ago 61% |
| BollingerBands ODDS (%) | 2 days ago 79% | 2 days ago 44% |
| Aroon ODDS (%) | 2 days ago 63% | 2 days ago 71% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
GKOS’s FA Score shows that 0 FA rating(s) are green while ISRG’s FA Score has 0 green FA rating(s).
- GKOS’s FA Score: 0 green, 5 red.
- ISRG’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
GKOS’s TA Score shows that 5 TA indicator(s) are bullish while ISRG’s TA Score has 5 bullish TA indicator(s).
- GKOS’s TA Score: 5 bullish, 4 bearish.
- ISRG’s TA Score: 5 bullish, 5 bearish.
Price Growth
GKOS (@Medical/Nursing Services) experienced а +5.35% price change this week, while ISRG (@Pharmaceuticals: Other) price change was +0.43% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.15%. For the same industry, the average monthly price growth was -6.04%, and the average quarterly price growth was -2.68%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.26%. For the same industry, the average monthly price growth was -5.19%, and the average quarterly price growth was +14.13%.
Reported Earning Dates
GKOS is expected to report earnings on Nov 04, 2026.
ISRG is expected to report earnings on Oct 20, 2026.
Industries' Descriptions
@Medical/Nursing Services (-2.15% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Pharmaceuticals: Other (-2.26% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
Advertisement
GKOS and
Correlation & Price change
A.I.dvisor indicates that over the last year, GKOS has been loosely correlated with ISRG. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if GKOS jumps, then ISRG could also see price increases.
| Ticker / NAME | Correlation To GKOS | 1D Price Change % | ||
|---|---|---|---|---|
| GKOS | 100% | -0.62% | ||
| ISRG - GKOS | 51% Loosely correlated | -1.33% | ||
| NTRA - GKOS | 48% Loosely correlated | -1.17% | ||
| RDNT - GKOS | 48% Loosely correlated | -1.80% | ||
| TWST - GKOS | 46% Loosely correlated | -2.69% | ||
| ALGN - GKOS | 43% Loosely correlated | -0.00% | ||
More | ||||
ISRG and
Correlation & Price change
A.I.dvisor indicates that over the last year, ISRG has been closely correlated with BSX. These tickers have moved in lockstep 73% of the time. This A.I.-generated data suggests there is a high statistical probability that if ISRG jumps, then BSX could also see price increases.
| Ticker / NAME | Correlation To ISRG | 1D Price Change % | ||
|---|---|---|---|---|
| ISRG | 100% | -1.33% | ||
| BSX - ISRG | 73% Closely correlated | -0.96% | ||
| SYK - ISRG | 64% Loosely correlated | -0.88% | ||
| NTRA - ISRG | 54% Loosely correlated | -1.17% | ||
| GKOS - ISRG | 51% Loosely correlated | -0.62% | ||
| PODD - ISRG | 49% Loosely correlated | +0.25% | ||
More | ||||